Alfons J. van den Eertwegh

In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.

Alfons J. van den Eertwegh, Randolph J. Noelle, Michael Roy et al. · The Journal of Experimental Medicine · 1993 · 249 citations · Full text

Lymphocyte Development, Adaptive Immune System, T-regulatory Cell +18

Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions.

David M. Calderhead, Janet E. Buhlmann, Alfons J. van den Eertwegh et al. · The Journal of Immunology · 1993 · 204 citations

Clinical Effects of Adjuvant Active Specific Immunotherapy Differ between Patients with Microsatellite-Stable and Microsatellite-Instable Colon Cancer

Vincent A. de Weger, Annelies W. Turksma, Quirinus J.M. Voorham et al. · Clinical Cancer Research · 2011 · 67 citations

Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy

Annelies W. Turksma, Veerle M.H. Coupé, Marc C. Shamier et al. · Clinical Cancer Research · 2015 · 52 citations

Expanded phase I combination trial of GVAX immunotherapy for prostate cancer and ipilimumab in patients with metastatic hormone-refractory prostate cancer (mHPRC)

W.R. Gerritsen, Alfons J. van den Eertwegh, Tanja D. de Gruijl et al. · Journal of Clinical Oncology · 2008 · 44 citations

Urology, Gvax Immunotherapy, Genitourinary Cancer +15